Australia's Race Oncology rises on announcing share buyback
** Shares of pharma co Race Oncology RAC.AX climb as much
as 17.8% to A$1.990, their highest since June 1
** Co approves an on-market share buyback for up to 4 mln
ordinary shares over the next 12 months urn:newsml:reuters.com:*:nASX21Gng8
** Says shares will be purchased at a price of not more than
5% above the 5-day volume weighted average price of RAC shares
** Shares mark their biggest intraday gain since May 31
** As of last close, stock down 53.1% this year
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220